Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples